Actualités

Moderna (NASDAQ:MRNA) announced on Thursday that the U. S.

Apple Inc. has asked a U.S. judge to issue a preliminary injunction preventing two former employees and OpenAI from accessing, using, or disclosing alleged confidential information while its trade secrets lawsuit proceeds. Apple asked the court to require former employees...

The Food and Drug Administration approved Moderna’s mRNA-based flu vaccine for adults ages 50 and older, clearing the first shot of its kind after a review process that nearly collapsed in February. The vaccine, called mFlusiva, uses the same mRNA technology as Moderna’s Covid-19 shots. It could reach pharmacies in time for the coming flu season, which typically starts in the fall.

Food safety scares and recalls have pressured restaurant and grocery stocks in 2026, raising concerns about costs, supply chains, and brand trust.

The lawsuit was filed in California, which has a law that bans deceptive reference prices.

(Update with New Jersey Attorney General Jennifer Davenport's statement on the lawsuit in the penult

NHTSA just labeled over 135,000 Ford vehicles an unreasonable safety risk, and the agency has not finished with Ford yet. With 36 recalls already logged in 2026 and a billion dollars in promised warranty savings on the line, the pressure on Jim Farley is reaching a breaking point.

Apple (AAPL) asked a US judge for a preliminary injunction barring ChatGPT maker OpenAI and two form

The ChatGPT maker said Apple is using selective and false information, hours after Apple sought an injunction in the case.

A European court rejected Broadcom's attempt to block regulators from demanding U.S.-based VMware legal documents.

An executive’s exit from the entertainment giant reminds us what a minefield ‘bring your whole self to work’ can be.

California’s governor warns that an antitrust lawsuit threatening the media mega-merger could severely damage local entertainment industry jobs.

Microsoft faces an August 11 Copilot lawsuit deadline, days after the biggest one-day market cap gain in US history.

The California governor has told people involved in the suit that blocking the $81 billion deal could harm Hollywood jobs.

A Massachusetts couple who ran an e-commerce newsletter started receiving anonymous packages containing live cockroaches, a fetal pig, and death threats, and it took years before the full scope of who orchestrated the campaign against them came to light.

NEW YORK, July 30 (Reuters) - Coinbase won the dismissal on Thursday of much of a lawsuit in which customers accused the largest U. ‌cryptocurrency exchange of illegally selling securities without registering as an exchange or ‌broker-dealer.

Hims & Hers shares crashed yesterday as the FTC filed a lawsuit against the telehealth provider. Here’s how you should play HIMS stock at current levels.

Boston Scientific recently reported its second-quarter 2026 results, showing sales of US$5,442 million and net income of US$907 million, alongside issuing a recall of its Rapid Refill Continuous Injection System and initiating a multi-year global restructuring plan aimed at cost efficiencies. While the company raised full-year 2026 net sales growth expectations to approximately 5.5%–6.5%, it also outlined a restructuring program costing up to US$800 million and targeting around US$500...

Warren and Schiff want an SEC investigation into Trump Media's Truth API, the $100,000 paid feed launching August 1. Two precedents show how it ends.

Walmart stock has delivered a strong 151.4% return over the past five years, yet the latest Discounted Cash Flow (DCF) estimate points to the shares trading at a premium to intrinsic value, while market based multiples suggest pricing that is closer to fair. Over the past five years, a 151.4% total return highlights how much of Walmart's long term value story may already be reflected in the share price. Walmart's dominant grocery position and partnerships that support better inventory...

The payout resolves a 2021 civil lawsuit brought by newsletter publishers David and Ina Steiner over a 2019 campaign to silence their reporting

Johnson & Johnson says it will pay an estimated $5.5 billion to settle about 76,000 lawsuits alleging its baby powder and talc caused ovarian cancer.

Johnson & Johnson has set aside $5.5 billion to resolve tens of thousands of US lawsuits alleging that its talcum powder-based products caused ovarian cancer.

The deal covers about 76,000 ovarian cancer claims and requires acceptance by at least 95% of claimants to take effect

Johnson & Johnson has offered $5.5 billion to settle tens of thousands of lawsuits claiming its baby powder and other talcum powder products caused ovarian cancer, the company says.

Johnson & Johnson (J&J) has offered to pay $5.5bn (£4.13bn) to resolve tens of thousands of lawsuits in the US alleging its talcum powder caused ovarian cancer. The company said the settlement covers around 76,000 claims, having already settled most cases alleging its talc contained asbestos and caused mesothelioma. J&J's vice president of litigation, Erik Haas, said the move was motivated by a desire to get closure – describing the claims themselves as "meritless".

In the midst of an expensive AI transformation, the company is grappling with litigation that could cost it billions and force painful changes.

The company said it reached an agreement with firms representing plaintiffs in the outstanding talc cases to pay up to $3 billion in claim payments in 2027, with no further payments due before 2028.

NEW YORK, July 27 (Reuters) - The former JPMorgan Chase banker whose lurid sexual harassment lawsuit went viral added new claims and defendants on Monday, saying the largest U. bank's acceptance of racism and sexual coercion irreparably destroyed his ‌career.

Ford just issued recalls covering nearly a million vehicles, and while that spells trouble for its own shareholders, a handful of publicly traded dealer groups are quietly positioned to profit from every car that rolls into the service bay.